Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Candidates for routine, uncomplicated cataract surgery~In Investigator's opinion, potential postoperative Snellen Distance VA by pinhole method of at least 20/200 in study eye.~Exclusion Criteria:~* Known hypersensitivity/contraindication to study product(s) or components.~* History of glaucoma, intraocular pressure (IOP) \>21 mmHg at the screening or randomization visits, or being treated for glaucoma in either eye.~* Diagnosis of: ongoing ocular infection; severe/serious ocular condition that in judgment of Investigator could confound study assessments or limit compliance; severe/serious systemic disease or uncontrolled medical condition that in judgment of Investigator could confound study assessments or limit compliance; or have been exposed to an investigational drug within the 30 days prior to screening or 18 days following surgery.~* In the opinion of Investigator or study coordinator, be unwilling or unable to comply with study protocol or unable to successfully instill eye drops.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- KPI-121 1.0% Ophthalmic Suspension (Type: ACTIVE_COMPARATOR): dosed BID
- Vehicle of KPI-121 Ophthalmic Suspension (Type: PLACEBO_COMPARATOR): dosed BID

Based on this trial design, predict the completion outcome and termination type (if applicable).